Recent

% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • riffissimo riffissimo Dec 11, 2012 2:54 PM Flag

    Frankly if the pipeline works half as well as appears early on...

    ...ISIS should be valued at $30B ($300 per share).

    It's the goose that lays the golden eggs.

    News from today's call. STAT3rx has two (2 of 2) durable partial responses in diffuse large b-cell lymphoma. This means at least a 50% shrinkage of tumor lasting six months are more. This is exceptional early data. It's approaching unprecedented. Prepare for major buzz near term, possibly by ASCO.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ISIS
65.16-0.17(-0.26%)Apr 20 4:00 PMEDT